Compare NVO & C Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVO | C |
|---|---|---|
| Founded | 1923 | 1812 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.6B | 193.7B |
| IPO Year | N/A | N/A |
| Metric | NVO | C |
|---|---|---|
| Price | $38.55 | $106.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $51.00 | ★ $124.50 |
| AVG Volume (30 Days) | ★ 21.6M | 11.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.15% | 2.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.84 |
| Revenue Next Year | $4.39 | $3.86 |
| P/E Ratio | ★ $13.60 | $16.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.85 | $55.51 |
| 52 Week High | $82.23 | $125.16 |
| Indicator | NVO | C |
|---|---|---|
| Relative Strength Index (RSI) | 31.52 | 37.95 |
| Support Level | N/A | $92.68 |
| Resistance Level | $50.30 | $124.06 |
| Average True Range (ATR) | 0.89 | 3.62 |
| MACD | -0.21 | -0.72 |
| Stochastic Oscillator | 19.46 | 21.79 |
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Citigroup is a global financial-services company doing business in more than 160 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.